Tanaka M, Yamashita SI, Yoshinaga Y, Enomoto Y, et al. Combination of DYRK2 and TERT Expression Is a Powerful Predictive Marker for Early-stage Breast Cancer Recurrence. Anticancer Res 2022;42:2079-2085.
PMID: 35347031